Literature DB >> 19956105

Reassessment of the type I diabetes association of the OAS1 locus.

H-Q Qu1, C Polychronakos.   

Abstract

To reassess the type I diabetes (T1D) association of the OAS1 locus, the Type I Diabetes Genetics Consortium (T1DGC) genotyped 11 tag single-nucleotide polymorphisms spanning approximately 41 kb from the 5' to 3' flanking region. For each sample obtained from over 2000 affected sib-pair families from nine cohorts, the genotyping was performed on both the Illumina Golden Gate and Sequenom iPlex platforms. The data suggest that there may be a weak association with T1D for two OAS1 polymorphisms, rs3741981 and rs10774671, in populations of European descent. The OAS1 locus is close to a recently identified T1D-associated linkage disequilibrium (LD) block in human chromosome 12q24. Extended LD in populations earlier examined may account for the prior observation of an association of T1D with OAS1 variants. This possibility needs to be addressed further by fine mapping of the T1D association represented in 12q24.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19956105      PMCID: PMC2805449          DOI: 10.1038/gene.2009.95

Source DB:  PubMed          Journal:  Genes Immun        ISSN: 1466-4879            Impact factor:   2.676


  12 in total

Review 1.  Gene structure and function of the 2'-5'-oligoadenylate synthetase family.

Authors:  J Justesen; R Hartmann; N O Kjeldgaard
Journal:  Cell Mol Life Sci       Date:  2000-10       Impact factor: 9.261

2.  The family based association test method: strategies for studying general genotype--phenotype associations.

Authors:  S Horvath; X Xu; N M Laird
Journal:  Eur J Hum Genet       Date:  2001-04       Impact factor: 4.246

3.  No evidence for association of OAS1 with type 1 diabetes in unaffected siblings or type 1 diabetic cases.

Authors:  Deborah J Smyth; Jason D Cooper; Christopher E Lowe; Sarah Nutland; Neil M Walker; David G Clayton; John A Todd
Journal:  Diabetes       Date:  2006-05       Impact factor: 9.461

4.  Type 1 diabetes and the OAS gene cluster: association with splicing polymorphism or haplotype?

Authors:  M-C Tessier; H-Q Qu; R Fréchette; F Bacot; R Grabs; S P Taback; M L Lawson; S E Kirsch; T J Hudson; C Polychronakos
Journal:  J Med Genet       Date:  2005-07-13       Impact factor: 6.318

5.  Variation in antiviral 2',5'-oligoadenylate synthetase (2'5'AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene.

Authors:  Vagn Bonnevie-Nielsen; L Leigh Field; Shao Lu; Dong-Jun Zheng; Min Li; Pia M Martensen; Thomas B Nielsen; Henning Beck-Nielsen; Yu-Lung Lau; Flemming Pociot
Journal:  Am J Hum Genet       Date:  2005-02-24       Impact factor: 11.025

6.  OAS1 splice site polymorphism controlling antiviral enzyme activity influences susceptibility to type 1 diabetes.

Authors:  L Leigh Field; Vagn Bonnevie-Nielsen; Flemming Pociot; Shao Lu; Thomas B Nielsen; Henning Beck-Nielsen
Journal:  Diabetes       Date:  2005-05       Impact factor: 9.461

7.  Positional cloning of the murine flavivirus resistance gene.

Authors:  Andrey A Perelygin; Svetlana V Scherbik; Igor B Zhulin; Bronislava M Stockman; Yan Li; Margo A Brinton
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-21       Impact factor: 11.205

8.  A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice.

Authors:  Tomoji Mashimo; Marianne Lucas; Dominique Simon-Chazottes; Marie-Pascale Frenkiel; Xavier Montagutelli; Pierre-Emmanuel Ceccaldi; Vincent Deubel; Jean-Louis Guenet; Philippe Despres
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-19       Impact factor: 11.205

9.  Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes.

Authors:  John A Todd; Neil M Walker; Jason D Cooper; Deborah J Smyth; Kate Downes; Vincent Plagnol; Rebecca Bailey; Sergey Nejentsev; Sarah F Field; Felicity Payne; Christopher E Lowe; Jeffrey S Szeszko; Jason P Hafler; Lauren Zeitels; Jennie H M Yang; Adrian Vella; Sarah Nutland; Helen E Stevens; Helen Schuilenburg; Gillian Coleman; Meeta Maisuria; William Meadows; Luc J Smink; Barry Healy; Oliver S Burren; Alex A C Lam; Nigel R Ovington; James Allen; Ellen Adlem; Hin-Tak Leung; Chris Wallace; Joanna M M Howson; Cristian Guja; Constantin Ionescu-Tîrgovişte; Matthew J Simmonds; Joanne M Heward; Stephen C L Gough; David B Dunger; Linda S Wicker; David G Clayton
Journal:  Nat Genet       Date:  2007-06-06       Impact factor: 38.330

10.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

View more
  11 in total

1.  Preliminary evidence of genetic determinants of adiponectin response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.

Authors:  S Aslibekyan; P An; A C Frazier-Wood; E K Kabagambe; M R Irvin; R J Straka; H K Tiwari; M Y Tsai; P N Hopkins; I B Borecki; J M Ordovas; D K Arnett
Journal:  Nutr Metab Cardiovasc Dis       Date:  2012-11-11       Impact factor: 4.222

Review 2.  Alternative splicing in multiple sclerosis and other autoimmune diseases.

Authors:  Irina Evsyukova; Jason A Somarelli; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2010-07-01       Impact factor: 4.652

3.  Overview of the Type I Diabetes Genetics Consortium.

Authors:  S S Rich; B Akolkar; P Concannon; H Erlich; J E Hilner; C Julier; G Morahan; J Nerup; C Nierras; F Pociot; J A Todd
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

4.  The Type I Diabetes Genetics Consortium 'Rapid Response' family-based candidate gene study: strategy, genes selection, and main outcome.

Authors:  C Julier; B Akolkar; P Concannon; G Morahan; C Nierras; A Pugliese
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

5.  Evaluate the relationship between polymorphisms of OAS1 gene and susceptibility to chronic hepatitis C with high resolution melting analysis.

Authors:  Yan Zhao; Hui Kang; Yangtang Ji; Xin Chen
Journal:  Clin Exp Med       Date:  2012-06-19       Impact factor: 3.984

6.  Identification of a new susceptibility variant for multiple sclerosis in OAS1 by population genetics analysis.

Authors:  Rachele Cagliani; Matteo Fumagalli; Franca R Guerini; Stefania Riva; Daniela Galimberti; Giacomo P Comi; Cristina Agliardi; Elio Scarpini; Uberto Pozzoli; Diego Forni; Domenico Caputo; Rosanna Asselta; Mara Biasin; Elvezia M Paraboschi; Nereo Bresolin; Mario Clerici; Manuela Sironi
Journal:  Hum Genet       Date:  2011-07-07       Impact factor: 4.132

Review 7.  Type I Interferon and the Spectrum of Susceptibility to Viral Infection and Autoimmune Disease: A Shared Genomic Signature.

Authors:  Jamie A Sugrue; Nollaig M Bourke; Cliona O'Farrelly
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

8.  Analysis of 19 genes for association with type I diabetes in the Type I Diabetes Genetics Consortium families.

Authors:  J M M Howson; N M Walker; D J Smyth; J A Todd
Journal:  Genes Immun       Date:  2009-12       Impact factor: 2.676

9.  Mitochondrial localization of the OAS1 p46 isoform associated with a common single nucleotide polymorphism.

Authors:  Karina Hansen Kjær; Jytte Pahus; Mariann Fagernæs Hansen; Jesper Buchhave Poulsen; Erik Ilsø Christensen; Just Justesen; Pia Møller Martensen
Journal:  BMC Cell Biol       Date:  2014-09-09       Impact factor: 4.241

10.  A functional variant in the OAS1 gene is associated with Sjögren's syndrome complicated with HBV infection.

Authors:  Xianjun Liu; Hongcun Xing; Wenjing Gao; Di Yu; Yuming Zhao; Xiaoju Shi; Kun Zhang; Pingya Li; Jiaao Yu; Wei Xu; Hongli Shan; Kaiyu Zhang; Wanguo Bao; Xueqi Fu; Sirui Yang; Shaofeng Wang
Journal:  Sci Rep       Date:  2017-12-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.